CRA International adds life sciences VP Hillan
Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash
CRA International appointed Patrick Hillan as Vice President for Life Sciences Commercial Strategy, deepening its leadership bench in a key sector. The move follows a second-quarter revenue beat, with the company reporting USD 210.81 million against an expected USD 198.91 million. Analysts maintain a Moderate Buy rating, with a target price significantly above the current stock value, citing recent performance and strategic growth in life sciences.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.